Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management

References

• Alexandraki K, Protogerou A D, Papaioannou T G, Piperi C, Mastorakos G, Lekakis J, et al. Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Hormones 2006; 5: 126–136
   PubMedGoogle Scholar
• Altuntas Y, Bilir M, Ucak S, Gundogdu S. Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2005; 119: 198–205
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004; 89: 2745–2749
   PubMed Web of Science ®Google Scholar
• Banaszewska B, Pawelczyk L, Spaczynski R Z, Dziura J, Duleba A J. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism 2007; 92: 456–461
   PubMed Web of Science ®Google Scholar
• Belli S H, Graffigna M N, Oneto A, Otero P, Schurman L, Levalle O A. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertility and Sterility 2004; 81: 624–629
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Yogev Y, Fisch B. Insulin resistance and metformin in polycystic ovary syndrome. European Journal of Obstetrics, Gynecology and Reproductive Biology 2004; 115: 125–133
   PubMed Web of Science ®Google Scholar
• Berneis K, Rizzo M, Lazzaroni V, Fruzzetti F, Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007; 92: 186–189
   PubMed Web of Science ®Google Scholar
• Borg P, Kukkonen-Harjula K, Fogelholm M, Pasanen M. Effects of walking or resistance training on weight loss maintenance in obese, middle-aged men: a randomized trial. International Journal of Obesity Related Metabolic Disorders 2002; 26: 676–683
   PubMed Web of Science ®Google Scholar
• Brehm B J, Seeley R J, Daniels S R, D'Alessio D A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. Journal of Clinical Endocrinology and Metabolism 2003; 88: 1617–1623
   PubMed Web of Science ®Google Scholar
• Brinkworth G, Noakes M, Keogh J, Luscombe N, Wittert G, Clifton P. Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects. International Journal of Obesity Related Metabolic Disorders 2004; 28: 661–670
   PubMed Web of Science ®Google Scholar
• Cai X J, Evans M L, Lister C A, Leslie R A, Arch J R, Wilson S, et al. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001; 50: 105–112
   PubMed Web of Science ®Google Scholar
• Cardillo S, Seshadri P, Iqbal N. The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year follow-up of a randomized trial. European Review for Medical and Pharmacological Sciences 2006; 10: 99–106
   PubMedGoogle Scholar
• Carmina E. Metabolic syndrome in polycystic ovary syndrome. Minerva Ginecologica 2006; 58: 109–114
   PubMedGoogle Scholar
• Chapelot D, Marmonier C, Aubert R, Allegre C, Gausseres N, Fantino M, et al. Consequence of omitting or adding a meal in man on body composition, food intake, and metabolism. Obesity 2006; 14: 215–227
   PubMed Web of Science ®Google Scholar
• Chavarro J E, Rich-Edwards J W, Rosner B A, Willett W C. Dietary fatty acid intakes and the risk of ovulatory infertility. American Journal of Clinical Nutrition 2007; 85: 231–237
   PubMed Web of Science ®Google Scholar
• Checa M A, Requena A, Salvador C, Tur R, Callejo J, Espinos J J, et al. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Human Reproduction Update 2005; 11: 375–390
   PubMed Web of Science ®Google Scholar
• Chen M-J, Yang W-S, Yang J-H, Hsiao C K, Yang Y-S, Ho H-N. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction 2006; 21: 2266–2271
   PubMed Web of Science ®Google Scholar
• Chen X, Ge Y-L, Jiang Z-Y, Liu C-Q, Depoortere I, Peeters T L. Effects of ghrelin on hypothalamic glucose responding neurons in rats. Brain Research 2005; 1055: 131–136
   PubMed Web of Science ®Google Scholar
• Coffey S, Bano G, Mason H D. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecological Endocrinology 2006; 22: 80–86
   PubMed Web of Science ®Google Scholar
• Corton M, Botella-Carretero J I, Benguria A, Villuendas G, Zaballos A, San Millan J L, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007; 92: 328–337
   PubMed Web of Science ®Google Scholar
• Crosignani P G, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human Reproduction 2003; 18: 1928–1932
   PubMed Web of Science ®Google Scholar
• Dahan M H, Goldstein J. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility 2006; 86: 934–941
   PubMed Web of Science ®Google Scholar
• Dansinger M L, Gleason J A, Griffith J L, Selker H P, Schaefer E J. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk Reduction: A Randomized Trial. Journal of the American Medical Association 2005; 293: 43–53
   PubMed Web of Science ®Google Scholar
• De Leo V, Musacchio M C, Morgante G, Piomboni P, Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Human Reproduction 2006; 21: 2252–2256
   PubMed Web of Science ®Google Scholar
• Dennehy C E. The use of herbs and dietary supplements in gynecology: an evidence-based review. Journal of Midwifery and Women's Health 2006; 51: 402–409
   PubMed Web of Science ®Google Scholar
• Despres J-P, Golay A, Sjostrom L, Rimonabant in Obesity-Lipids Study G. Effects of Rimonabant on metabolic risk factors in overweight patients with dyslipidemia. New England Journal of Medicine 2005; 353: 2121–2134
   PubMed Web of Science ®Google Scholar
• Dewan S, Gillett A, Mugarza J A, Dovey T M, Halford J CG, Wilding J PH. Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal. Diabetes/Metabolism Research Reviews 2004; 20: 405–410
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, et al. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2007; 56: 129–134
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Economou F. Stress in women: metabolic syndrome and polycystic ovary syndrome. Annals of the New York Academy of Sciences 2006; 1083: 54–62
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Piperi C, Alexandraki K, Katsilambros N, Kouroupi E, Papailiou J, et al. Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2006; 55: 494–500
   PubMed Web of Science ®Google Scholar
• Douglas C C, Gower B A, Darnell B E, Ovalle F, Oster R A, Azziz R. Role of diet in the treatment of polycystic ovary syndrome. Fertility and Sterility 2006; 85: 679–688
   PubMed Web of Science ®Google Scholar
• Drazen D L, Vahl T P, D'Alessio D A, Seeley R J, Woods S C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006; 147: 23–30
   PubMed Web of Science ®Google Scholar
• Duleba A J, Banaszewska B, Spaczynski R Z, Pawelczyk L. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertility and Sterility 2006; 85: 996–1001
   PubMed Web of Science ®Google Scholar
• Ehrmann D A. Polycystic ovary syndrome. New England Journal of Medicine 2005; 352: 1223–1236
   PubMed Web of Science ®Google Scholar
• Elting M W, Korsen T JM, Schoemaker J. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Clinical Endocrinology 2001; 55: 767–776
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale H F, Botella-Carretero J I, Villuendas G, Sancho J, San Millan J L. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. Journal of Clinical Endocrinology and Metabolism 2004; 89: 806–811
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale H F, Villuendas G, Botella-Carretero J I, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Human Reproduction 2006; 21: 2257–2265
   PubMed Web of Science ®Google Scholar
• Farnsworth E, Luscombe N D, Noakes M, Wittert G, Argyiou E, Clifton P M. Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. American Journal of Clinical Nutrition 2003; 78: 31–39
   PubMed Web of Science ®Google Scholar
• Farshchi H, Taylor M, Macdonald I. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. International Journal of Obesity Related Metabolic Disorders 2004; 28: 653–660
   PubMed Web of Science ®Google Scholar
• Farshchi H, Taylor M, Macdonald I. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. American Journal of Clinical Nutrition 2005; 81: 388–396
   PubMed Web of Science ®Google Scholar
• Farshchi H, Taylor M, Macdonald I. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. European Journal of Clinical Nutrition 2004; 58: 1071–1077
   PubMed Web of Science ®Google Scholar
• Farshchi H R, Taylor M A, Macdonald I A. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. American Journal of Clinical Nutrition 2005; 81: 16–24
   PubMed Web of Science ®Google Scholar
• Filippatos T D, Kiortsis D N, Liberopoulos E N, Mikhailidis D P, Elisaf M S. A review of the metabolic effects of sibutramine. Current Medical Research and Opinion 2005; 21: 457–468
   PubMed Web of Science ®Google Scholar
• Foster G D, Wyatt H R, Hill J O, McGuckin B G, Brill C, Mohammed B S, et al. A Randomized Trial of a Low-Carbohydrate Diet for Obesity. New England Journal of Medicine 2003; 348: 2082–2090
   PubMed Web of Science ®Google Scholar
• Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate A M, Cavazza C, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2006; 91: 3970–3980
   PubMed Web of Science ®Google Scholar
• Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the Polycystic Ovary Syndrome. International Journal of Obesity 2002; 26: 883–896
   PubMed Web of Science ®Google Scholar
• Gannon M C, Nuttall F Q, Saeed A, Jordan K, Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. American Journal of Clinical Nutrition 2003; 78: 734–741
   PubMed Web of Science ®Google Scholar
• Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrom V, Flyvbjerg A, et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. European Journal of Endocrinology 2006; 155: 337–345
   PubMed Web of Science ®Google Scholar
• Glintborg D, Hermann A P, Andersen M, Hagen C, Beck-Nielsen H, Veldhuis J D, et al. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome. Fertility and Sterility 2006; 86: 385–397
   PubMed Web of Science ®Google Scholar
• Glueck C J, Aregawi D, Agloria M, Winiarska M, Sieve L, Wang P. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2006; 55: 1582–1589
   PubMed Web of Science ®Google Scholar
• Glueck C J, Aregawi D, Winiarska M, Agloria M, Luo G, Sieve L, et al. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. Journal of Pediatric Endocrinology 2006; 19: 831–842
   PubMed Web of Science ®Google Scholar
• Glueck C J, Moreira A, Goldenberg N, Sieve L, Wang P. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin. Human Reproduction 2003; 18: 1618–1625
   PubMed Web of Science ®Google Scholar
• Goldenberg N, Glueck C J, Loftspring M, Sherman A, Wang P. Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance. Metabolism: Clinical and Experimental 2005; 54: 113–121
   PubMed Web of Science ®Google Scholar
• Gonzalez F, Rote N S, Minium J, Kirwan J P. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006; 91: 1508–1512
   PubMed Web of Science ®Google Scholar
• Goodarzi M O, Erickson S, Port S C, Jennrich R I, Korenman S G. Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome. Metabolism 2003; 52: 713–719
   PubMed Web of Science ®Google Scholar
• Gulcelik N E, Aral Y, Serter R, Demir Y, Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology 2006; 22: 511–515
   PubMed Web of Science ®Google Scholar
• Gulseren L, Cetinay P, Tokatlioglu B, Sarikaya O O, Gulseren S, Kurt S. Depression and anxiety levels in infertile Turkish women. Journal of Reproductive Medicine 2006; 51: 421–426
   PubMed Web of Science ®Google Scholar
• Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experimental and Clinical Endocrinology and Diabetes 2006; 114: 577–583
   PubMed Web of Science ®Google Scholar
• Hardiman P, Pillay O S, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. The Lancet 2003; 361: 1810–1812
   PubMed Web of Science ®Google Scholar
• Harnack L, Jeffery R, Boutelle K. Temporal trends in energy intake in the United States: an ecologic perspective. American Journal of Clinical Nutrition 2000; 71: 1478–1484
   PubMed Web of Science ®Google Scholar
• Himelein M J, Thatcher S S. Depression and body image among women with polycystic ovary syndrome. Journal of Health Psychology 2006; 11: 613–625
   PubMed Web of Science ®Google Scholar
• Himelein M J, Thatcher S S. Polycystic ovary syndrome and mental health: A review. Obstetrical and Gynecological Survey 2006; 61: 723–732
   PubMed Web of Science ®Google Scholar
• Hoeger K M. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Practice and Research Clinical Endocrinology and Metabolism 2006; 20: 293–310
   PubMed Web of Science ®Google Scholar
• Jakicic J M, Marcus B H, Gallagher K I, Napolitano M, Lang W. Effect of Exercise Duration and Intensity on Weight Loss in Overweight, Sedentary Women: A Randomized Trial. Journal of the American Medical Association 2003; 290: 1323–1330
   PubMed Web of Science ®Google Scholar
• Jayagopal V, Kilpatrick E S, Holding S, Jennings P E, Atkin S L. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2005; 90: 729–733
   PubMed Web of Science ®Google Scholar
• Jeffery R W, Wing R R, Sherwood N E, Tate D F. Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?. American Journal of Clinical Nutrition 2003; 78: 684–689
   PubMed Web of Science ®Google Scholar
• Karabacak I YNI, Karabacak O, Toruner F B, Akdemir O, Arslan M. Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease. Gynecological Endocrinology 2004; 19: 196–201
   PubMed Web of Science ®Google Scholar
• Kasim-Karakas S E, Almario R U, Gregory L, Wong R, Todd H, Lasley B L. Metabolic and Endocrine Effects of a Polyunsaturated Fatty Acid-Rich Diet in Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism 2004; 89: 615–620
   PubMed Web of Science ®Google Scholar
• Kennedy R L, Chokkalingam K, Farshchi H R. Nutrition in patients with Type 2 diabetes: are low-carbohydrate diets effective, safe or desirable?. Diabetic Medicine 2005; 22: 821–832
   PubMed Web of Science ®Google Scholar
• Kerver J M, Yang E J, Obayashi S, Bianchi L, Song W O. Meal and snack patterns are associated with dietary intake of energy and nutrients in US adults. Journal of the American Dietetic Association 2006; 106: 46–53
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Human Reproduction 2001; 16: 1255–1260
   PubMed Web of Science ®Google Scholar
• Kwiterovich P O, Jr, Vining E PG, Pyzik P, Skolasky R, Jr, Freeman J M. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. Journal of the American Medical Association 2003; 290: 912–920
   PubMed Web of Science ®Google Scholar
• Layman D K, Boileau R A, Erickson D J, Painter J E, Shiue H, Sather C, et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. Journal of Nutrition 2003; 133: 411–417
   PubMed Web of Science ®Google Scholar
• Lemay A, Dodin S, Turcot L, Dechene F, Forest J C. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. Human Reproduction 2006; 21: 121–128
   PubMed Web of Science ®Google Scholar
• Levin B E. Glucosensing neurons do more than just sense glucose. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2001; 25(Suppl)S68–S72
   PubMed Web of Science ®Google Scholar
• Liu X H, Morris R, Spiller D, White M, Williams G. Orexin a preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro. Diabetes 2001; 50: 2431–2437
   PubMed Web of Science ®Google Scholar
• Lo J C, Feigenbaum S L, Escobar G J, Yang J, Crites Y M, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 2006; 29: 1915–1917
   PubMed Web of Science ®Google Scholar
• Majuri A, Santaniemi M, Rautio K, Kunnari A, Vartiainen J, Ruokonen A, et al. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. European Journal of Endocrinology 2007; 156: 263–269
   PubMed Web of Science ®Google Scholar
• Marsh K, Brand-Miller J. The optimal diet for women with polycystic ovary syndrome?. British Journal of Nutrition 2005; 94: 154–165
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Lambrinoudaki I, Creatsas G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatric Drugs 2006; 8: 311–318
   PubMedGoogle Scholar
• McAuley K A, Hopkins C M, Smith K J, McLay R T, Williams S M, Taylor R W, et al. Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 2005; 48: 8–16
   PubMed Web of Science ®Google Scholar
• Merhi Z O. Weight loss by bariatric surgery and subsequent fertility. Fertility and Sterility 2007; 87: 430–432
   PubMed Web of Science ®Google Scholar
• Mitkov M, Pehlivanov B, Terzieva D. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2006; 126: 93–98
   PubMed Web of Science ®Google Scholar
• Mor E, Zograbyan A, Saadat P, Bayrak A, Tourgeman D E, Zhang C, et al. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. American Journal of Obstetrics and Gynecology 2004; 190: 1654–1660
   PubMed Web of Science ®Google Scholar
• Moran L J, Noakes M, Clifton P M, Tomlinson L, Galletly C, Norman R J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003; 88: 812–819
   PubMed Web of Science ®Google Scholar
• Moran L J, Noakes M, Clifton P M, Wittert G A, Williams G, Norman R J. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. American Journal of Clinical Nutrition 2006; 84: 77–87
   PubMed Web of Science ®Google Scholar
• Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Human Reproduction 2007; 22: 317–322
   PubMed Web of Science ®Google Scholar
• Nordmann A J, Nordmann A, Briel M, Keller U, Yancy W S, Jr, Brehm B J, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2006; 166: 285–293, [erratum appears in Archives of Internal Medicine 2006; 166:932]
   PubMed Web of Science ®Google Scholar
• Norman R J, Noakes M, Wu R, Davies M J, Moran L, Wang J X. Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update 2004; 10: 267–280
   PubMed Web of Science ®Google Scholar
• Parker B, Noakes M, Luscombe N, Clifton P. Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 2002; 25: 425–430
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2767–2774
   PubMed Web of Science ®Google Scholar
• Pelusi B, Gambineri A, Pasquali R. Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecologica 2004; 56: 41–51
   PubMedGoogle Scholar
• Pi-Sunyer F X, Aronne L J, Heshmati H M, Devin J, Rosenstock J, Group RI-NAS. Effect of Rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. Journal of the American Medical Association 2006; 295: 761–775, [erratum appears in Journal of the American Medical Association 2006; 295:1252]
   PubMed Web of Science ®Google Scholar
• Poehlman E T, Dvorak R V, DeNino W F, Brochu M, Ades P A. Effects of Resistance Training and Endurance Training on Insulin Sensitivity in Nonobese, Young Women: A Controlled Randomized Trial. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2463–2468
   PubMed Web of Science ®Google Scholar
• Rautio K, Tapanainen J S, Ruokonen A, Morin-Papunen L C. Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study. Fertility and Sterility 2007; 87: 202–206
   PubMed Web of Science ®Google Scholar
• Reimer R A, Debert C T, House J L, Poulin M J. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy. Physiology and Behavior 2005; 84: 303–312
   PubMed Web of Science ®Google Scholar
• Riccardi G, Rivellese A. Dietary treatment of the metabolic syndrome – the optimal diet. British Journal of Nutrition 2000; 83: S143–S148
   PubMed Web of Science ®Google Scholar
• Sabuncu T, Harma M, Harma M, Nazligul Y, Kilic F. Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertility and Sterility 2003; 80: 1199–1204
   PubMed Web of Science ®Google Scholar
• Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity?. Metabolism 2004; 53: 358–376
   PubMed Web of Science ®Google Scholar
• Samaha F F, Iqbal N, Seshadri P, Chicano K L, Daily D A, McGrory J, et al. A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity. New England Journal of Medicine 2003; 348: 2074–2081
   PubMed Web of Science ®Google Scholar
• Sartor B M, Dickey R P. Polycystic ovarian syndrome and the metabolic syndrome. American Journal of the Medical Sciences 2005; 330: 336–342
   PubMed Web of Science ®Google Scholar
• Sharman M J, Gomez A L, Kraemer W J, Volek J S. Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men. Journal of Nutrition 2004; 134: 880–885
   PubMed Web of Science ®Google Scholar
• Sjoberg A, Hallberg L, Hoglund D, Hulthen L. Meal pattern, food choice, nutrient intake and lifestyle factors in The Goteborg Adolescence Study. European Journal of Clinical Nutrition 2003; 57: 1569–1578
   PubMed Web of Science ®Google Scholar
• Smith S R, De Jonge L, Volaufova J, Li Y, Xie H, Bray G A. Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. Metabolism: Clinical and Experimental 2005; 54: 24–32
   PubMed Web of Science ®Google Scholar
• Stamets K, Taylor D S, Kunselman A, Demers L M, Pelkman C L, Legro R S. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertility and Sterility 2004; 81: 630–637
   PubMed Web of Science ®Google Scholar
• Stein K. Polycystic ovarian syndrome: what it is and why registered dietitians need to know. Journal of the American Dietetic Association 2006; 106: 1738–1741
   PubMedGoogle Scholar
• Stern L, Iqbal N, Seshadri P, Chicano K L, Daily D A, McGrory J, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Annals of Internal Medicine 2004; 140: 778–785
   PubMed Web of Science ®Google Scholar
• Tang T, Glanville J, Hayden C J, White D, Barth J H, Balen A H. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Human Reproduction 2006; 21: 80–89
   PubMed Web of Science ®Google Scholar
• Topcu S, Caliskan M, Ozcimen E E, Tok D, Uckuyu A, Erdogan D, et al. Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?. Human Reproduction 2006; 21: 930–935
   PubMed Web of Science ®Google Scholar
• Van Dam E WCM, Roelfsema F, Veldhuis J D, Helmerhorst F M, Frolich M, Meinders A E, et al. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. American Journal of Physiology – Endocrinology and Metabolism 2002; 282: E865–E872
   PubMed Web of Science ®Google Scholar
• van Dam E WCM, Roelfsema F, Veldhuis J D, Hogendoorn S, Westenberg J, Helmerhorst F M, et al. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome. American Journal of Physiology – Endocrinology and Metabolism 2004; 286: E615–E620
   PubMed Web of Science ®Google Scholar
• Van Gaal L F, Rissanen A M, Scheen A J, Ziegler O, Rossner S, Group RI-ES. Effects of the cannabinoid-1 receptor blocker Rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389–1397, [erratum appears in Lancet 2005 366:370]
   PubMed Web of Science ®Google Scholar
• Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese A A, Tapsell L C, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 2001; 44: 312–319
   PubMed Web of Science ®Google Scholar
• Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Current Opinion in Lipidology 2003; 14: 15–19
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Dvorakova K, Hill M, Starka L. Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary. Endocrine Regulations 2006; 40: 119–123
   PubMedGoogle Scholar
• Wang J X, Davies M J, Norman R J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Human Reproduction 2001; 16: 2606–2609
   PubMed Web of Science ®Google Scholar
• Westphal L M, Polan M L, Trant A S. Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clinical and Experimental Obstetrics and Gynecology 2006; 33: 205–208
   PubMedGoogle Scholar
• Wild R A. Long-term health consequences of PCOS. Human Reproduction Update 2002; 8: 231–241
   PubMed Web of Science ®Google Scholar
• Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertility and Sterility 2003; 79: 1358–1364
   PubMed Web of Science ®Google Scholar
• Zhang Y F, Yang Y S, Hong J, Gu W Q, Shen C F, Xu M, et al. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 2006; 29: 419–423
   PubMed Web of Science ®Google Scholar